The Food and Drug Administration approved Endomagnetics Inc.’s magnetic tracer injection and detection system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. In the procedure, the clinician injects a solution of dextran-coated iron oxide magnetic nanoparticles (Magtrace) in the viscinity of the tumour or (Read more...)